Vitreoretinal Disorder market size is expected to reach $6.71 billion by 2030 at 7.7%, growing incidence of diabetic retinopathy fueling the growth of the market due to rising retinal complications
Read MoreGlobal Vitiligo Treatment market size is expected to reach $2.02 billion by 2030 at 5.6%, the rise in healthcare expenditure
Read MoreVitamin d testing market to reach $1.56 billion by 2030 at 9.1% cagr, driven by increasing awareness of vitamin d deficiency disorders.
Read MoreVisual impairment market to reach $5.97 billion by 2030 at 6.6% CAGR, driven by rising diabetes prevalence and early detection of complications.
Read MoreVisual arts therapy market to reach $4.45 billion by 2030 at 17.9% cagr, driven by growing incidence of mental health problems.
Read MoreThe viscosupplementation treatment for arthritis market will reach $5.98 by 2030 at 7.4% CAGR, driven by aging population, advanced HA therapies, and outpatient care.
Read MoreGlobal Visceral Pain market size is expected to reach $19.6 billion by 2030 at 5.7%, segmented as by calcium channel blockers, dihydropyridines, non-dihydropyridines
Read MoreVisceral Leishmaniasis market size is expected to reach $1.39 billion by 2030 at 5.5%, rise in malnutrition fueling the growth of the market due to weakened immunity and increasing susceptibility
Read MoreVirtual Rehabilitation market size is expected to reach $2.46 billion by 2030 at 24.6%, driven by increasing prevalence of disabilities.
Read MoreThe VR vision therapy market will reach $3.87 billion by 2030 at 20.9% CAGR, driven by home-based VR therapy, AI personalization, telehealth, and immersive mixed-reality applications.
Read More